Lakefront Biotherapeutics · EURONEXT:LKFT

Madison Avenue Partners, LP reported a 5.50% stake in Lakefront Biotherapeutics (Schedule 13G)

Event Jun 15, 2026 · Filed Jun 23, 2026

Madison Avenue Partners, LP reported a 5.50% stake in Lakefront Biotherapeutics, 3,606,203 shares, as a passive investor on Jun 15, 2026. Filed Jun 23, 2026 (Schedule 13G).

Stake
5.50%
Shares
3,606,203
Intent
Passive
What changed
Crossed above 5%
Filed together
6 holders

The filing in full

HolderStakeShares
Madison Avenue International LP5.50%3,606,203
Madison Avenue Partners, LP5.50%3,606,203
EMAI Management, LLC5.50%3,606,203
Madison Avenue GP, LLC5.50%3,606,203
Caraway Jackson Investments LLC5.50%3,606,203
Eli Samaha5.50%3,606,203

Source

View original at SEC

Related